SDAM
CVS icon

Shulman DeMeo Asset Management’s CVS Health CVS Stock Holding History

Shulman DeMeo Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Buy
2,803
+9
+0.3% +$803 0.05% 113
2026
Q1 		$201K Buy
2,794
+13
+0.5% +$1K 0.04% 130
2025
Q4 		$221K Buy
2,781
+21
+0.8% +$1.66K 0.05% 106
2025
Q3 		$208K Buy
+2,760
New +$189K 0.05% 110
2024
Q4 		– Sell
-2,787
Closed -$253K – 122
2024
Q3 		$253K Buy
+2,787
New +$163K 0.06% 112
2024
Q2 		– Sell
-2,751
Closed -$219K – 130
2024
Q1 		$219K Buy
2,751
+3
+0.1% +$229 0.06% 119
2023
Q4 		$217K Buy
+2,748
New +$196K 0.06% 118
2023
Q2 		– Sell
-2,935
Closed -$218K – 132
2023
Q1 		$218K Buy
2,935
+10
+0.3% +$839 0.07% 121
2022
Q4 		$273K Sell
2,925
-21
-0.7% -$2.03K 0.09% 104
2022
Q3 		$281K Sell
2,946
-21
-0.7% -$2.08K 0.1% 99
2022
Q2 		$275K Buy
2,967
+241
+9% +$23.5K 0.09% 106
2022
Q1 		$276K Buy
2,726
+62
+2% +$6.51K 0.08% 112
2021
Q4 		$275K Buy
2,664
+14
+0.5% +$1.29K 0.07% 115
2021
Q3 		$225K Buy
+2,650
New +$222K 0.2% 74

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Shulman DeMeo Asset Management's CVS Position: Q2 2026 in Review

Shulman DeMeo Asset Management increased its CVS Health (CVS) stake by 0.32% in Q2 2026, buying an estimated $803 and bringing the position to 2,803 shares worth $290K. The position accounts for 0.05% of the portfolio, ranked #113.

Shulman DeMeo Asset Management first reported a position in CVS in Q3 2021 and has held it in 14 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Shulman DeMeo Asset Management held 2,803 shares of CVS Health worth $290K as of Q2 2026.
  • Shulman DeMeo Asset Management bought 9 CVS Health shares in Q2 2026, an estimated $803.
  • CVS Health made up 0.05% of Shulman DeMeo Asset Management's portfolio in Q2 2026, its #113 holding.
  • Shulman DeMeo Asset Management first reported a position in CVS Health in Q3 2021 and has held it in 14 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Shulman DeMeo Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.